巨子生物完成配售合共3500万股

格隆汇资讯
Yesterday

格隆汇4月28日丨巨子生物(02367.HK)公告,公司欣然宣布,卖方配售已于2025年4月23日完成,而认购则已于2025年4月28日完成。补足卖方所持有的合共3500万股股份已按每股66.65港元的配售价成功配售予不少于六名专业、机构及╱或个人投资者,据董事作出一切合理查询后所深知、尽悉及确信,该等投资者连同彼等各自最终实益拥有人均为独立于本公司或其关连人士且与彼等概无关连的第三方。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10